The GLOW Blend is supplied as a 70mg lyophilized white powder per vial, consisting of 50mg GHK-Cu, 10mg BPC-157, and 10mg Thymosin Beta 4 (TB-500), prepared exclusively for laboratory reconstitution and controlled experimental evaluation
However, there were a fair number of reports saying Thymosin Beta-4 increases the secretion of pro-inflammatory compounds
For detailed protocols matching published research standards, our peptide storage guide provides specific guidance on aliquoting, handling, and shelf-life considerations used in laboratory research
its a sign your bodys firing on all four cylinders
doi: 10.1111/jocd.15763 L.Pickart, A.Margolina, Regenerative and Protective Actions of the GHK-Cu
Immediately discontinue peptide administration in the event of a severe adverse reaction in research